<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01696279</url>
  </required_header>
  <id_info>
    <org_study_id>SPD405-207</org_study_id>
    <secondary_id>2012-000171-17</secondary_id>
    <nct_id>NCT01696279</nct_id>
  </id_info>
  <brief_title>A Comparison of Lanthanum Carbonate and Calcium Carbonate in Children</brief_title>
  <official_title>A 3-part Open-label Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Compare the Efficacy, Safety and Tolerability of 8 Weeks of Treatment With Lanthanum Carbonate and Calcium Carbonate Using a Crossover Design and Investigate the Efficacy and Safety of 8 Months of Treatment With Lanthanum Carbonate in Hyperphosphataemic Children and Adolescents Aged 10 Years to &lt;18 Years With Chronic Kidney Disease on Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Shire</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Shire</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To provide information about the safety and efficacy of lanthanum carbonate in children
      compared to standard treatment.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 11, 2013</start_date>
  <completion_date type="Anticipated">July 9, 2018</completion_date>
  <primary_completion_date type="Anticipated">July 2, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of subjects achieving age-specific Kidney Disease Outcomes Quality Initiative (KDOQI) targets for serum phosphorus</measure>
    <time_frame>8 Weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in serum phosphorus at up to 8 weeks</measure>
    <time_frame>Baseline and up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Calcium Levels at up to 8 weeks</measure>
    <time_frame>Baseline and up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Calcium-Phosphorous Product at up to 8 Weeks</measure>
    <time_frame>Baseline and up to 8 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum Plasma Concentration (Cmax) of Lanthanum Carbonate</measure>
    <time_frame>over 48 hours post-dose on Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Area Under the Plasma Concentration-Time Curve from time Zero to the Time of the Last Quantifiable Concentration (AUC0-t) of Lanthanum Carbonate</measure>
    <time_frame>over 48 hours post-dose on Day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in serum phosphorus at up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Calcium Levels at up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Calcium-Phosphorous Product at up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline in Bone Alkaline Phosphatase (ALP) at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Tartrate-Resistant Acid Phosphatase (TRAP) at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline Osteocalcin levels at Up to 10</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Fibroblast Growth factor 23 (FGF-23) Levels at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Parathyroid Hormone (PTH) Levels at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Sclerostin Levels at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Fetuin-A Levels at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Height at up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from Baseline in Weight at Up to 10 Months</measure>
    <time_frame>Baseline and up to 10 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Hyperphosphatemia</condition>
  <arm_group>
    <arm_group_label>Lanthanum Carbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Calcium Carbonate</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lanthanum carbonate</intervention_name>
    <description>Subjects will receive Lanthanum carbonate orally at a total daily dose of 1500 mg to 3000 mg divided equally between three meals.</description>
    <arm_group_label>Lanthanum Carbonate</arm_group_label>
    <other_name>Fosrenol</other_name>
    <other_name>SPD405</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Calcium carbonate</intervention_name>
    <description>Subjects will receive Calcium carbonate orally at a total daily dose taken by the subject prior to starting the study or equivalent. For new subjects, dosing will be based on standard clinical practice. The total daily dose may be adjusted as appropriate, until the target serum phosphorus level is achieved or until a maximum daily dose of 6500mg is reached.</description>
    <arm_group_label>Calcium Carbonate</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Aged 10 years to less than 18 years of age at the time of consent

          2. Serum phosphorus levels as follows:

               -  Age less than 12 years: Serum phosphorus greater than 6.0 mg/dL (1.94 mmol/L)

               -  Age 12 years and older: Serum phosphorus greater than 5.5 mg/dL (1.78 mmol/L)

        Exclusion Criteria:

          1. Unable to eat semi-solid foods or on Total Enteral Alimentation

          2. Serum PTH greater than 700 pg/mL

          3. Serum calcium greater than 10.2 mg/dL (2.54 mmol/L)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>10 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shire Study Physician</last_name>
    <role>Principal Investigator</role>
    <affiliation>Shire</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shire Contact</last_name>
    <email>clinicaltransparency@shire.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centro Infantil Del Rinon S.R.L</name>
      <address>
        <city>San Miguel de Tucuman</city>
        <state>Tucuman</state>
        <zip>4000</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital de Ninos Ricardo Gutierrez</name>
      <address>
        <city>Buenos Aires</city>
        <zip>C1425EFD</zip>
        <country>Argentina</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Specialized Hospital For Active Treatment In Pediatrics-Sofia Nephrology And Haemodialysis Clinic</name>
      <address>
        <city>Sofia</city>
        <zip>1606</zip>
        <country>Bulgaria</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Hospital Luis Calvo Mackenna</name>
      <address>
        <city>Santiago</city>
        <zip>7500539</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hospital Dr. Sotero del Rio</name>
      <address>
        <city>Santiago</city>
        <zip>8207257</zip>
        <country>Chile</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Fakultni nemocnice Ostrava</name>
      <address>
        <city>Ostrava</city>
        <zip>70852</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eliska Gelnarova</last_name>
      <phone>420 597 373 563</phone>
      <email>tomas.zaoral@fno.cz</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Prague 5</city>
        <zip>15006</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location>
    <facility>
      <name>Kinder-und Jugendklinik Erlangen</name>
      <address>
        <city>Erlangen</city>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Medizinische Hochschule Hannover</name>
      <address>
        <city>Hannover</city>
        <zip>30625</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem Altalanos Orvostudomanyi Kar</name>
      <address>
        <city>Budapest</city>
        <state>Bokay Janos</state>
        <zip>1083</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Istvanne Bori</last_name>
      <phone>00 361 330374</phone>
      <email>borikati@freemail.hu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Orvos- es Egeszsegtudomanyi Centrum</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Imrene Banyasz</last_name>
      <email>tundebanyasz@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Szegedi Tudomanyegyetem Altalanos Orvostudomanyi Kar</name>
      <address>
        <city>Szeged</city>
        <zip>6720</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Dzieciecy Szpital Kliniczny</name>
      <address>
        <city>Bialystok</city>
        <zip>15-274</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Malgorzata Smolko</last_name>
      <phone>48857450823</phone>
      <email>gosia.smolko@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Uniwersyteckie Centrum Kliniczne</name>
      <address>
        <city>Gdansk</city>
        <zip>80952</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Dzieciecy w Krakowie, Klinika Nefrologii Dzieciecej ze Stacja Dializ</name>
      <address>
        <city>Krakow</city>
        <zip>30663</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Teresa Smolnik</last_name>
      <email>teresa.smolnik@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>NZOZ tri-Medica</name>
      <address>
        <city>Lodz</city>
        <zip>93-338</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marcin Tkaczyk, Prof</last_name>
      <phone>+48 42 271 17 60</phone>
      <email>mtkaczyk@uni.lodz.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Dzieciecy Szpital Kliniczny im. Prof. A. Gebali,Klinika Pediatrii i Nefrologii z Podstacja Dializ</name>
      <address>
        <city>Lublin</city>
        <zip>20-093</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Uniwersytecki Szpital Kliniczny</name>
      <address>
        <city>Wroclaw</city>
        <zip>50556</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Danuta Zwolinska</last_name>
      <phone>+48 71.736.44.00</phone>
      <email>danuta.zwolinska@umed.wroc.pl</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta pentru Copii Sf. Maria</name>
      <address>
        <city>Iasi</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Spitalul Clinic de Urgenta pentru Copii - Louis Turcanu</name>
      <address>
        <city>Timisoara</city>
        <zip>300350</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claudia Comlosan</last_name>
      <phone>40744820491</phone>
      <email>laura.stefanescu@iconplc.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Children City Clinical Hospital of Saint Vladimir</name>
      <address>
        <city>Moscow</city>
        <zip>107014</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Muzurov</last_name>
      <email>muz_al@rambler.ru</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Saint-Petersburg State Budgetary Healthcare Institution &quot;Children City Hospital #1&quot;</name>
      <address>
        <city>Saint-Petersburg</city>
        <zip>198205</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aleksey Shavkin, MD</last_name>
      <phone>00 7 812 735 4838</phone>
      <email>dialys.dgb@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>State Budgetary Healthcare Instit. of Sverdlov Region &quot;Regional Children Clinical Hosp # 1&quot;</name>
      <address>
        <city>Yekaterinburg</city>
        <zip>620143</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>University of KwaZulu Natal</name>
      <address>
        <city>Durban</city>
        <zip>4001</zip>
        <country>South Africa</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Cukurova University Faculty of Medicine Paediatric Nephrology</name>
      <address>
        <city>Adana</city>
        <zip>01330</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Safak Oznergiz, Dr.</last_name>
      <phone>+90 322 3386935</phone>
      <email>safakoznergiz@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Izmir Tepecik Training and Research Hospital</name>
      <address>
        <city>Izmir</city>
        <zip>4500</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sevginar Senturk</last_name>
      <email>sevginarsenturk@mynet.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Inonu University Faculty of Medicine Department of Pediatric Health and Disease</name>
      <address>
        <city>Malatya</city>
        <zip>44280</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Withdrawn</status>
  </location>
  <location>
    <facility>
      <name>Manisa Celal Bayar University Hafsa Sultan Hospital</name>
      <address>
        <city>Manisa</city>
        <zip>45030</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yildiz Yesil</last_name>
      <phone>90 5323710830</phone>
      <email>yldzysl@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Argentina</country>
    <country>Bulgaria</country>
    <country>Chile</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Hungary</country>
    <country>Poland</country>
    <country>Romania</country>
    <country>Russian Federation</country>
    <country>South Africa</country>
    <country>Turkey</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2012</study_first_submitted>
  <study_first_submitted_qc>September 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 1, 2012</study_first_posted>
  <last_update_submitted>January 25, 2017</last_update_submitted>
  <last_update_submitted_qc>January 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperphosphatemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Calcium, Dietary</mesh_term>
    <mesh_term>Calcium Carbonate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

